Global Registry for Endovascular Aortic Treatment (GREAT)

Active, not recruiting

• Conditions: Multiple Pathologies
• Interventions: Device: Endovascular aortic repair

• Registration Number: NCT01658787
• Lead Sponsor: W.L.Gore & Associates

Brief Summary

Prospective, observational Registry to obtain data on device performance and clinical outcomes.

Detailed Description

This is a prospective observational cohort Registry designed to obtain data on device performance and clinical outcomes of patients treated with Gore Endovascular Aortic products.

Study Timeline

• Study Start: 2010-12
• Study First Submitted: 2012-08-03
• Study First Submitted QC: 2012-08-03
• Study First Posted: 2012-08-07
• Status Verified: 2024-07
• Last Update Submitted: 2024-10-07
• Last Update Posted: 2024-10-10
• Primary Completion: 2027-06
• Study Completion: 2027-06

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 4600

Inclusion Criteria

• Minimum age required by state regulations
• Indication for aortic endovascular stent graft repair
• Signed informed consent

Exclusion Criteria

• N/A

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Endovascular aortic repair	Endovascular aortic repair	Patients treated with Gore Endovascular Aortic Products.

Primary Outcome Measures

Name	Time	Method
To collect "real world" data on the incidence of serious device events.	Up to 10 years

Trial Locations

Locations (6)

Royal Prince Alfred Hospital; 🇦🇺 Camperdown, New South Wales, Australia

The University of Chicago Medicine & Biological Sciences; 🇺🇸 Chicago, Illinois, United States

Baylor Research Institute; 🇺🇸 Plano, Texas, United States

IRCCS Policlinico San Donato; 🇮🇹 Milano, Italy

Coris Medicina Avançada; 🇧🇷 Florianópolis, Brazil

Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico; 🇮🇹 Milano, Italy